Director, Digitized Case Processing & Digital Adverse Event Interfaces

Working with Us

Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

What if your next role actually mattered – not just to your career, but to patients around the world?

At Bristol Myers Squibb, we believe that getting patient safety information right – faster, smarter, and more reliably, isn’t just an operational goal. It’s a moral one. Every adverse event we capture more accurately, every process we automate with precision, every AI model we govern responsibly: it all traces back to a real person whose safety depends on us getting it right.

That’s the weight and the privilege of this role. And if that excites rather than intimidates you, read on.

What are we actually looking for?

We’re looking for a Director of Digitized Case Processing & Digital Adverse Event Interfaces – a leader who sits comfortably at the crossroads of pharmacovigilance science, cutting-edge technology, global regulation, and people leadership.

You’re probably already senior in your PV career. You’ve led teams, managed vendors, survived inspections, and built interfaces that actually work. But you’re restless. You’ve seen how much of PV case intake is still manual, slow, and fragile and you’ve been thinking about how to change it. You’ve got opinions about AI in GxP environments, about touchless processing, and about how literature screening should be done in 2026 and beyond.

This is the role where those opinions become strategy and that strategy becomes reality.

Here’s what you’ll actually be doing

• Leading the AI-powered transformation of adverse event intake – You’ll define and own BMS’s multi-year digital intake roadmap, deploying AI/NLP, OCR, RPA, LLMs, and Agentic AI to build genuinely automated, touchless AE case creation workflows, all within a validated GxP framework.
• Owning the interfaces that connect BMS’s safety ecosystem – From Medical Information and Clinical Development teams to CROs, licensing partners, and regulatory portals like FAERS, EudraVigilance, MHRA, and PMDA, you’ll own every channel through which adverse event data flows in and out of BMS.
• Reinventing how BMS screens medical literature – You’ll lead the digital transformation of BMS’s Medical Literature Screening programme moving to AI/NLP-driven screening across global databases including PubMed, EMBASE, Cochrane, and J‑Stage.
• Building and leading a world‑class global team – You’ll lead a geographically distributed team across the US, UK, Switzerland, India, and Japan, building a culture of psychological safety, scientific rigour, and continuous improvement.
• Turning data into decisions – You’ll design and own the KPI framework for your function, touchless processing rates, intake cycle times, data completeness, literature screening accuracy, and vendor SLA performance.

What you’ll bring to the table

You’ll need 10+ years in Pharmacovigilance or Drug Safety, including at least 3–5 years at Director level, and a minimum of 7 years of hands‑on experience in ICSR data acquisition, case intake, or processing in pharma, biotech, or CRO environments.

What truly sets you apart is your ability to take a digital transformation vision and make it real — translating ambiguous future‑state thinking into clear, actionable roadmaps that get delivered. You’re equally at home in a regulatory conversation about ICH E2B(R3) compliance and a technical deep‑deep dive on AI/NLP classifier performance. You’ve been in the room during FDA, EMA, MHRA, and PMDA inspections — and you know what inspection‑readiness really requires.

Ideally, you’ll also bring

• Experience deploying AI, NLP, OCR, or RPA in a GxP‑regulated environment
• A proven track record building AE data interfaces with internal and external partners
• Literature screening programme management, including AI‑assisted platforms
• Deep knowledge of ICH E2B(R3) across at least two major ICH regions
• Familiarity with ARIS Global LifeSphere, Oracle Argus, or Veeva Vault Safety
• Experience managing cross‑regional teams and exposure to AI governance in life sciences

BMS has an occupancy structure that determines where an employee is required to conduct their work. Site‑by‑design roles may be eligible for a hybrid work model with at least 50% onsite at your assigned facility. BMS is dedicated to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace accommodations/adjustments and ongoing support in their roles.

#J-18808-Ljbffr…